35
Participants
Start Date
July 9, 2022
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Acoziborole
"Two different mode of administration will be used during the study depending on the body weight and on the step of the study:~whole tablets of 320 mg dose for paediatric patients weighing 30 to 40 kg in step 1 whole or crushed tablets for paediatric patients weighing 10 to 40 kg in step 2"
General Hospital of Bandundu, Bandundu Province
CDTC Katanda, Katanda
Hôpital Général de Dipumba, Mbuji-Mayi
HGR Bagata, Bagata
Hospital of Masi-Manimba, Masi-Manimba
General Referral Hospital of Dubreka, Dubréka
Drugs for Neglected Diseases
OTHER